Published in Ann Surg on August 01, 2003
The endothelin/nitric oxide balance determines small-for-size liver injury after reduced-size rat liver transplantation. Virchows Arch (2005) 0.84
Altered cellular membrane fluidity levels and lipid peroxidation during experimental pancreas transplantation. J Bioenerg Biomembr (2012) 0.83
Interleukin-17 expression in murine pressure ulcer tissues. Exp Ther Med (2013) 0.77
Repeated gene transfection impairs the engraftment of transplanted porcine neonatal pancreatic cells. Diabetes Metab J (2011) 0.75
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet (2000) 3.16
Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest (1989) 2.69
Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet (1990) 1.49
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev (2002) 1.37
Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells. Basic Res Cardiol (2000) 1.01
Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery (1997) 1.01
The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg (1992) 0.97
Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow". Am J Physiol (1992) 0.96
Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J Physiol Pharmacol (1997) 0.96
Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut (2000) 0.95
Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery (2000) 0.92
Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: a new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3. J Clin Endocrinol Metab (1997) 0.91
Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia. Shock (1999) 0.90
Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. J Gastrointest Surg (2000) 0.90
Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Ann Surg (1998) 0.89
Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg (2001) 0.89
Effects of endothelin on microcirculation of the pancreas. Life Sci (1992) 0.89
Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients. Transplantation (1993) 0.88
Microcirculation in chronic alcoholic pancreatitis: a laser Doppler flow study. Pancreas (1999) 0.87
The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation (2001) 0.87
Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. J Gastrointest Surg (2000) 0.87
Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation (2000) 0.84
Endothelins: polyfunctional cytokines. J Am Coll Surg (1995) 0.84
The role of shear forces in ischemia/reperfusion-induced neutrophil rolling and adhesion. J Leukoc Biol (1997) 0.83
Attenuation of microvascular reperfusion injury in rat pancreas transplantation by L-arginine. Transplantation (1999) 0.82
Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation (2001) 0.81
The nitric oxide donor sodium nitroprusside is protective in ischemia/reperfusion injury of the pancreas. Transplantation (1998) 0.81
Characterization and reduction of ischemia/reperfusion injury after experimental pancreas transplantation. J Gastrointest Surg (2000) 0.81
Massive regional differences in the vascular effects of endothelin. J Hypertens Suppl (1989) 0.80
Exocrine, but not endocrine, tissue is susceptible to microvascular ischemia/reperfusion injury following pancreas transplantation in the rat. Transpl Int (1999) 0.80
Impairment of pancreatic microcirculation in the early reperfusion period during simultaneous pancreas-kidney transplantation. Transpl Int (1998) 0.80
Ischemia/reperfusion injury of the pancreas: a new animal model. J Surg Res (1998) 0.80
Protease activation following reperfusion of porcine pancreatic allografts. J Surg Res (1992) 0.80
Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis (1996) 0.78
Importance of the first minutes of reperfusion in hepatic preservation injury. Transplant Proc (1995) 0.77
Regional pancreatic perfusion. An experimental study in the dog. Acta Chir Scand (1986) 0.77
Optimal route of administration of mixed endothelin receptor antagonist (TAK-044) in liver transplantation. J Gastroenterol (2000) 0.77
Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Transplantation (1999) 0.77
Endothelin-A receptor antagonism improves small bowel graft perfusion and structure after ischemia and reperfusion. Transplantation (1999) 0.77
Microcirculatory events in ischemia/reperfusion of the pancreas defined by continuous tissue oximetry. Transpl Int (2002) 0.76
Lyme borreliosis. Lancet Infect Dis (2003) 4.58
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol (2006) 4.04
Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg (2003) 4.03
IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med (2003) 3.29
Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease. Gastrointest Endosc (2007) 2.27
Complicated small-bowel diverticulosis: a case report and review of the literature. World J Gastroenterol (2007) 2.20
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix. Int J Gynecol Pathol (2006) 2.04
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care (2007) 2.04
Serum levels of the adipokine progranulin depend on renal function. Diabetes Care (2012) 2.03
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg (2006) 2.03
Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes (2007) 1.96
TFAP2E-DKK4 and chemoresistance in colorectal cancer. N Engl J Med (2012) 1.94
Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab (2004) 1.92
Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab (2005) 1.87
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem (2008) 1.87
ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol (2010) 1.87
Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care (2007) 1.85
Functional assessment of pancreatic beta-cell area in humans. Diabetes (2009) 1.82
Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg (2007) 1.79
Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes (2007) 1.78
Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis (2010) 1.77
Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J (2007) 1.76
Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol (2006) 1.76
Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int (2013) 1.72
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch (2011) 1.72
IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70
Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer (2008) 1.68
A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection. Genome Biol (2014) 1.60
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Epigenetic silencing of the PTEN gene in melanoma. Cancer Res (2006) 1.58
Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies. Clin Chim Acta (2008) 1.56
Comparison of adrenal function tests in children--the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children. J Pediatr Endocrinol Metab (2005) 1.55
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene (2005) 1.55
Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats. Hypertension (2004) 1.50
Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf) (2014) 1.49
Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet (2013) 1.48
Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer (2011) 1.47
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res (2003) 1.47
Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells. J Mol Med (Berl) (2003) 1.45
Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol (2012) 1.45
The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes. Proc Natl Acad Sci U S A (2007) 1.45
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer (2009) 1.44
High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem (2007) 1.43
Increased activation of the transcription factor c-Jun by MAP kinases in monocytes of multiple trauma patients is associated with adverse outcome and mass transfusion. J Surg Res (2012) 1.43
Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care (2008) 1.42
Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices. Clin Chem Lab Med (2008) 1.42
Elevated sex steroid hormones in great saphenous veins in men. J Vasc Surg (2010) 1.41
Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy (2012) 1.39
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol (2003) 1.36
Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer (2003) 1.35
Caroli's disease: liver resection and liver transplantation. Experience in 33 patients. Surgery (2005) 1.34
Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea. Lab Invest (2003) 1.33
Determination of temperature elevation in tissue during the application of the harmonic scalpel. Ultrasound Med Biol (2003) 1.32
Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene (2003) 1.32
MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest (2011) 1.30
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia. Atherosclerosis (2007) 1.29
Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany. Eur J Hum Genet (2010) 1.26
Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One (2010) 1.25
Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res (2009) 1.25
Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch Surg (2008) 1.21
Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol (2009) 1.21
Phenotypic differences in behavior, physiology and neurochemistry between rats selected for tameness and for defensive aggression towards humans. Horm Behav (2007) 1.19
Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab (2007) 1.19
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer (2012) 1.18
Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior. Front Hum Neurosci (2011) 1.17
Genetic architecture of tameness in a rat model of animal domestication. Genetics (2009) 1.15
Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci U S A (2012) 1.14
Ductal pancreatic adenocarcinoma. Dtsch Arztebl Int (2014) 1.14
Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration. Oncogene (2003) 1.14
Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab (2004) 1.14
Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer (2005) 1.13
Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol (2003) 1.12
DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet (2015) 1.12
Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant (2006) 1.11
Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species. PLoS One (2012) 1.11
Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab (2007) 1.11
Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A (2013) 1.10
Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer (2008) 1.10
Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer. J Mol Med (Berl) (2006) 1.10
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother (2009) 1.08
Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets. Transplantation (2005) 1.08
Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis (2008) 1.08
Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2010) 1.07
Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf) (2008) 1.07
Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun (2005) 1.06
New predictors of the metabolic syndrome in children--role of adipocytokines. Pediatr Res (2007) 1.06
Adipocytes and adipose tissue. Best Pract Res Clin Endocrinol Metab (2008) 1.06
Altered immune response in mice deficient for the G protein-coupled receptor GPR34. J Biol Chem (2010) 1.05